According to our in vitro data, Orlistat treatment induced significant tumor volume reduction versus vehicle‐exposed animals (Agostini et al, 2014), in mice carrying EGFR mutant PC‐9GR and H1975 xenografts, by 58 and 49%, respectively. Here, EGFR is linked to neoplasm.